Immunic Historical Financial Ratios
| IMUX Stock | USD 1.27 0.06 4.96% |
Immunic is lately reporting on over 113 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.34 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Immunic financial condition quickly.
Immunic |
About Immunic Financial Ratios Analysis
ImmunicFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Immunic investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Immunic financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Immunic history.
Immunic Financial Ratios Chart
Immunic financial ratios usually calculated using numerical values taken directly from Immunic financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Immunic. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Immunic's Book Value Per Share is fairly stable compared to the past year. Invested Capital is likely to rise to 0.05 in 2024, whereas PTB Ratio is likely to drop 1.34 in 2024. Add Fundamental
Dividend Yield
Dividend Yield is Immunic dividend as a percentage of Immunic stock price. Immunic dividend yield is a measure of Immunic stock productivity, which can be interpreted as interest rate earned on an Immunic investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Most ratios from Immunic's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Immunic current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.At this time, Immunic's Book Value Per Share is fairly stable compared to the past year. Invested Capital is likely to rise to 0.05 in 2024, whereas PTB Ratio is likely to drop 1.34 in 2024.
| 2021 | 2023 | 2024 (projected) | Net Debt To EBITDA | 0.94 | 0.46 | 0.43 | Intangibles To Total Assets | 0.24 | 0.27 | 0.34 |
Immunic fundamentals Correlations
Click cells to compare fundamentals
Immunic Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immunic fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 1.28 | 1.51 | 1.78 | 0.39 | 2.3 | 1.34 | |
| Book Value Per Share | 7.56 | 10.14 | 5.37 | 3.57 | 0.65 | 0.69 | |
| Free Cash Flow Yield | (0.38) | (0.19) | (0.37) | (1.46) | (1.07) | (1.12) | |
| Operating Cash Flow Per Share | (3.7) | (2.94) | (3.52) | (2.05) | (1.6) | (1.68) | |
| Capex To Depreciation | (1.1) | (3.74) | (0.79) | (1.45) | (3.01) | (2.86) | |
| Pb Ratio | 1.28 | 1.51 | 1.78 | 0.39 | 2.3 | 1.34 | |
| Free Cash Flow Per Share | (3.7) | (2.95) | (3.52) | (2.05) | (1.61) | (1.69) | |
| Roic | (0.59) | (0.3) | (0.71) | (1.32) | (3.21) | (3.05) | |
| Net Income Per Share | (4.51) | (2.81) | (3.92) | (4.85) | (2.11) | (2.22) | |
| Cash Per Share | 3.8 | 8.14 | 3.67 | 3.66 | 1.05 | 1.0 | |
| Pocfratio | (2.62) | (5.19) | (2.72) | (0.68) | (0.94) | (0.99) | |
| Capex To Operating Cash Flow | 0.001927 | 0.003165 | 8.05E-4 | 0.001719 | 0.004716 | 0.00448 | |
| Pfcf Ratio | (2.62) | (5.18) | (2.72) | (0.68) | (0.93) | (0.98) | |
| Income Quality | 0.82 | 1.05 | 0.9 | 0.54 | 0.76 | 1.02 | |
| Roe | (0.6) | (0.28) | (0.73) | (1.36) | (3.24) | (3.07) | |
| Ev To Operating Cash Flow | (1.61) | (2.44) | (1.68) | 0.93 | (0.3) | (0.31) | |
| Pe Ratio | (2.15) | (5.45) | (2.44) | (0.29) | (0.71) | (0.75) | |
| Ev To Free Cash Flow | (1.61) | (2.44) | (1.68) | 0.93 | (0.3) | (0.31) | |
| Net Debt To E B I T D A | 0.78 | 2.59 | 0.94 | 1.96 | 0.46 | 0.43 | |
| Current Ratio | 4.56 | 15.93 | 9.21 | 9.62 | 2.12 | 2.02 | |
| Tangible Book Value Per Share | (0.98) | 5.93 | 2.59 | 3.57 | 0.65 | 0.69 | |
| Graham Number | 27.69 | 25.3 | 21.78 | 19.74 | 5.57 | 5.29 | |
| Shareholders Equity Per Share | 7.56 | 10.14 | 5.37 | 3.57 | 0.65 | 0.69 | |
| Capex Per Share | (0.007122) | (0.009321) | (0.002833) | (0.00352) | (0.007536) | (0.007913) | |
| Graham Net Net | 2.83 | 7.74 | 3.19 | 3.24 | 0.49 | 0.52 | |
| Enterprise Value Over E B I T D A | (1.25) | (2.3) | (1.53) | 1.13 | (0.21) | (0.22) | |
| Price Earnings Ratio | (2.15) | (5.45) | (2.44) | (0.29) | (0.71) | (0.75) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunic's short interest history, or implied volatility extrapolated from Immunic options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Immunic Stock analysis
When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Immunic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunic. If investors know Immunic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.11) | Return On Assets (0.68) | Return On Equity (1.31) |
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.